The medicines regulator Swissmedic says it has not yet received enough robust data from clinical trials to give the green light to the Covid-19 vaccine developed by the Swedish-British company.
While the supervisory authority saw conclusive results from studies involving many participants to approve two other coronavirus vaccines, the same could not be said for the Oxford-AstraZeneca shot, Swissmedic director Raimund Bruhin told the CH Media group of newspapers on Thursday.
But this did not mean that he believes the vaccine is a poor one.
“We are only saying that the company has not yet been able to prove to us that it is a good vaccine,” said Bruhin.
The approvals process, he added, was about hard data and facts. Last week Swissmedic received a large package of data from the pharmaceutical company, which it is now reviewing, and remains in regular contact with the makers of the vaccine.
Other countries, such as the United Kingdom, have been administering the AstraZeneca vaccine for over three months – although several nations have halted vaccinations in recent days over isolated cases of blood-clotting. The European Medicines Agency has said the benefits of the Oxford-AstraZeneca jab greatly outweigh the risks and on Thursday will issue a report on its investigation into cases of blood clots.
Switzerland has ordered more than 35 million doses of Covid-19 vaccines from five manufacturers. To date Swissmedic has approved shots developed by Pfizer/BioNTech and Moderna. Roughly 4% of the population has been vaccinated so far, but delays in approval and delivery have slowed the roll-out process.
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Switzerland to step up humanitarian aid to Lebanon and Syria
This content was published on
The Swiss government decided to allocate an additional CHF7 million to the two countries in response to the escalating violence in the Middle East.
Report exposes widespread hygiene issues in Swiss hospitals
This content was published on
A Swissmedic report found that nearly all of the 25 Swiss hospitals inspected had issues with disinfecting, sterilising and packaging of medical products.
Swiss bank Mirabaud closes brokerage unit due to poor performance
This content was published on
The move spanning the bank’s global operations means a loss of 17 jobs, including five each in Switzerland and the UK, and seven in Spain.
Guterres condemns Israel’s plan to label UNRWA a terrorist organisation
This content was published on
UN Secretary-General Antonio Guterres has spoken out against a law proposed by the Israeli parliament that would classify UNRWA as a terrorist organisation.
This content was published on
The Swiss federal technology institute ETH Zurich is the best university in continental Europe, according to the Times Higher Education ranking.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland could sell or give away AstraZeneca doses if regulator dithers
This content was published on
A lack of green light from medicines regulator Swissmedic could see 5.3 million doses ordered by Switzerland sent elsewhere.
This content was published on
Media reports indicate that vaccinating everyone who wants to by summer relies on meeting ambitious vaccine delivery targets in spring.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.